For example, class I HDACi were demonstrated to upregulate PD-L1/L2 surface protein and RNA transcription in melanoma patients, in melanoma cell lines and in a syngeneic mouse model of melanoma, through acetylation of the PD-L1 and PD-L2 promotor [164]. Here, PDCD1LG2 is linked to melanoma.